Tanvex BioPharma USA, Inc.
2 clinical trials · Sponsor
◉ Watch Tanvex BioPharma USA, Inc.
| Record | Firm | Date |
|---|---|---|
| Extension Study to Provide Adjuvant Treatment Following Neoadjuvant Treatment and Surgical Resection in Protocol TX05-03 (NCT04109391) | Tanvex BioPharma USA, Inc. | 2019-08-20 |
| Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast Cancer (NCT03556358) | Tanvex BioPharma USA, Inc. | 2018-06-28 |
Track Tanvex BioPharma USA, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.